Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Christopher C. Olsen"'
Publikováno v:
Unmanned Systems. :215-232
Autonomous unmanned vehicles are well suited for long-endurance, persistent intelligence, surveillance and reconnaissance (PISR) missions. In order to conduct missions, vehicles must implement a method of task selection. We propose the Maximal Distan
Autor:
Christopher C. Olsen, Donald L. Kunz
Publikováno v:
2018 International Conference on Unmanned Aircraft Systems (ICUAS).
We explore the suitability of the Maximal Distance Discounted & Weighted Revisit Period utility function as a basis for task selection by an autonomous aerial vehicle in the presence of operational factors. The vehicles must persistently visit tasks
Autor:
Christopher C. Olsen, Donald L. Kunz
Publikováno v:
2018 AIAA Information Systems-AIAA Infotech @ Aerospace.
Autor:
David W. Casbeer, Krishnamoorthy Kalyanam, Steven Rasmussen, Christopher C. Olsen, Satyanarayana G. Manyam
Publikováno v:
CCTA
We are interested in the persistent surveillance of an area of interest comprised of heterogeneous tasks (or targets) that need to be completed (or visited) in a repeated manner subject to constraints on time between successive visits. The task is un
Autor:
Christopher C. Olsen, Donald L. Kunz
Publikováno v:
AIAA Guidance, Navigation, and Control Conference.
Autor:
Igarashi A; Unit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, Kanazawa Ward, Yokohama, Kanagawa, Japan., Tanaka S; Graduate School of Medicine, Kyoto University, Kyoto, Japan., De Moor R; Value, Evidence and Access Department, IMAT, Janssen Pharmaceutical K.K., Tokyo, Japan., Li N; Value, Evidence and Access Department, IMAT, Janssen Pharmaceutical K.K., Tokyo, Japan., Hirozane M; Policy Department, IMAT, Janssen Pharmaceutical K.K., Tokyo, Japan., Wu DB; Asia Pacific Regional Market Access, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore., Hong LW; Asia Pacific Regional Market Access, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore, Singapore., Yu DY; Asia Pacific Regional Market Access, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore, Singapore., Hashim M; Johnson and Johnson Global Commercial Strategy Organization, Beerse, Belgium., Hutton B; Ottawa Hospital Research Institute, Ottawa, Canada., Tantakoun K; EVERSANA™, Burlington, ON, Canada., Olsen C; EVERSANA™, Burlington, ON, Canada., Fashami FM; EVERSANA™, Burlington, ON, Canada., Samjoo IA; EVERSANA™, Burlington, ON, Canada., Cameron C; EVERSANA™, Burlington, ON, Canada. chris.cameron@eversana.com.
Publikováno v:
Advances in therapy [Adv Ther] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.
Autor:
Tanaka S; Faculty of medicine, Kyoto University, Kyoto, Japan., Igarashi A; Unit of Public Health and Preventive Medicine, Yokohama City University School of Medicine, Yokohama, Japan., De Moor R; Value, Evidence and Access Department, IMAT, Janssen Pharmaceutical K.K., Tokyo, Japan., Li N; Value, Evidence and Access Department, IMAT, Janssen Pharmaceutical K.K., Tokyo, Japan., Hirozane M; Policy Department, IMAT, Janssen Pharmaceutical K.K., Tokyo, Japan., Hong LW; Asia Pacific Regional Market Access, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore., Wu DB; Asia Pacific Regional Market Access, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore., Yu DY; Asia Pacific Regional Market Access, Janssen Pharmaceutical Companies of Johnson and Johnson, Singapore., Hashim M; Janssen Vaccines and Prevention B.V., Leiden, The Netherlands., Hutton B; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Tantakoun K; Value and Evidence, EVERSANA, Burlington, ON, Canada., Olsen C; Value and Evidence, EVERSANA, Burlington, ON, Canada., Mirzayeh Fashami F; Value and Evidence, EVERSANA, Burlington, ON, Canada., Samjoo IA; Value and Evidence, EVERSANA, Burlington, ON, Canada., Cameron C; Value and Evidence, EVERSANA, Burlington, ON, Canada. Electronic address: chris.cameron@eversana.com.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Sep; Vol. 27 (9), pp. 1179-1190. Date of Electronic Publication: 2024 Jun 04.
Comparison of online to face-to-face instruction for anatomy review in a third-year clinical course.
Publikováno v:
The Journal of chiropractic education [J Chiropr Educ] 2024 Feb 08; Vol. 0 (0), pp. 0.
Autor:
Raber J; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States.; Departments of Neurology, and Radiation Medicine, Division of Neuroscience ONPRC, Oregon Health & Science University, Portland, OR, United States.; College of Pharmacy, Oregon State University, Corvallis, OR, United States., Holden S; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States., Kessler K; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States., Glaeser B; Neuroscience Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, United States., McQuesten C; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States., Chaudhari M; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States., Stenzel F; Department of Behavioral Neuroscience, Oregon Health & Science University, Portland, OR, United States., Lenarczyk M; Radiation Biosciences Laboratory, Medical College of Wisconsin, Milwaukee, WI, United States., Leonard SW; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States., Morré J; Mass Spectrometry Core, Oregon State University, Corvallis, OR, United States., Choi J; Linus Pauling Institute, Oregon State University, Corvallis, OR, United States., Kronenberg A; Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, United States., Borg A; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States., Kwok A; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States., Stevens JF; College of Pharmacy, Oregon State University, Corvallis, OR, United States.; Linus Pauling Institute, Oregon State University, Corvallis, OR, United States., Olsen C; Neuroscience Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, United States., Willey JS; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, NC, United States., Bobe G; Linus Pauling Institute, Oregon State University, Corvallis, OR, United States.; Department of Animal Sciences, Oregon State University, Corvallis, OR, United States., Minnier J; Oregon Health & Science University-Portland State University School of Public Health, Knight Cancer Institute Biostatistics Shared Resource, The Knight Cardiovascular Institute, OR Health & Science University, Portland, OR, United States., Baker JE; Neuroscience Center and Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, United States.
Publikováno v:
Frontiers in physiology [Front Physiol] 2024 Jan 08; Vol. 14, pp. 1316186. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).
Autor:
Olsen C; Division of Community Health and Humanities, HSC 2830A, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL, A1B 3V6, Canada., El-Bialy R; Division of Community Health and Humanities, HSC 2830A, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL, A1B 3V6, Canada., Mckelvie M; Division of Community Health and Humanities, HSC 2830A, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL, A1B 3V6, Canada., Rauman P; Division of Community Health and Humanities, HSC 2830A, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL, A1B 3V6, Canada., Brunger F; Division of Community Health and Humanities, HSC 2830A, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL, A1B 3V6, Canada. fbrunger@mun.ca.
Publikováno v:
Journal of immigrant and minority health [J Immigr Minor Health] 2016 Feb; Vol. 18 (1), pp. 58-66.